Jeff Baxter, President and CEO of VBI Vaccines Inc. (NASDAQ: VBIV), a commercial-stage biopharmaceutical company developing next-generation infectious disease and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE